| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.88▼ | 1.84▲ | 1.83▲ | 1.57▲ | 1.37▲ |
| MA10 | 1.87▼ | 1.82▲ | 1.76▲ | 1.39▲ | 1.32▲ |
| MA20 | 1.85▲ | 1.73▲ | 1.74▲ | 1.34▲ | 1.59▲ |
| MA50 | 1.80▲ | 1.65▲ | 1.45▲ | 1.30▲ | 3.21▼ |
| MA100 | 1.71▲ | 1.46▲ | 1.35▲ | 1.61▲ | 14.51▼ |
| MA200 | 1.76▲ | 1.34▲ | 1.31▲ | 2.79▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.010▲ | 0.005▲ | 0.075▲ | 0.274▲ |
| RSI | 59.106▲ | 60.474▲ | 60.723▲ | 74.582▲ | 42.253▼ |
| STOCH | 54.325 | 79.937 | 85.193▲ | 45.268 | 25.635 |
| WILL %R | -44.444 | -16.000▲ | -10.526▲ | -55.997 | -55.365 |
| CCI | 20.558 | 121.073▲ | 126.887▲ | 142.456▲ | 187.934▲ |
|
Wednesday, October 29, 2025 08:02 AM
ERNA-101 is based on Ernexa’s technology that engineers induced pluripotent stem cells into induced mesenchymal stem cells (iMSCs), which have a unique ability to migrate toward tumors. The therapy is ...
|
|
Wednesday, October 29, 2025 06:32 AM
THE WOODLANDS, Texas, and CAMBRIDGE, Mass., Oct. 29, 2025 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced it ...
|
|
Monday, September 29, 2025 01:30 AM
CAMBRIDGE, Mass., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/10/25 | 1.64 | 1.92 | 1.6201 | 1.88 | 725,268 |
| 30/10/25 | 1.75 | 1.78 | 1.52 | 1.78 | 2,420,600 |
| 29/10/25 | 2.175 | 2.8599 | 1.51 | 1.76 | 211,145,538 |
| 28/10/25 | 1.23 | 1.26 | 1.20 | 1.25 | 11,931 |
| 27/10/25 | 1.22 | 1.23 | 1.19 | 1.19 | 14,100 |
| 24/10/25 | 1.19 | 1.25 | 1.17 | 1.24 | 16,700 |
| 23/10/25 | 1.14 | 1.20 | 1.11 | 1.17 | 26,800 |
| 22/10/25 | 1.19 | 1.20 | 1.11 | 1.15 | 52,100 |
| 21/10/25 | 1.25 | 1.25 | 1.21 | 1.21 | 16,900 |
| 20/10/25 | 1.25 | 1.25 | 1.22 | 1.2493 | 10,785 |
|
|
||||
|
|
||||
|
|